Type 2 & other diabetes

Examining a Diabetes Self-Management Education and Support Telemedicine Model With High-Risk Patients in a Rural Community

J Diabetes Sci TechnolPublished Nonrandomised feasibility trial

Authors' conclusion

This feasibility study suggests that TREAT-ON was well-received and as effective as traditional in-person DSMES. While findings augment ample evidence regarding DSMES benefits, the TREAT-ON model offers additional advantages and provides validation for telehealth to inform future practice in reaching and supporting self-management for high-risk patients in underserved areas.

Study context

Population
High-risk patients with T2D and hemoglobin A1c (HbA1c) >9% in federally qualified health centers in a rural community
Exposure
Diabetes self-management education and support (DSMES) via videoconferencing vs in-person DSMES
  • Intervention group (IG)n = 30
Outcome
HbA1c change
Methodological details12-month, propensity score-matched retrospective control group, federally qualified health centers
  • 12-month
  • Propensity score-matched retrospective control group
  • Federally qualified health centers

Main finding

As reported in the abstract

  • IG had similar significant reductions in HbA1c as the control group (CG)

Observational data: associations, not effects.

Further findings

Self-management goal attainment (IG)
64%

HbA1c, diabetes distress and dietary intake in goal attainers (IG)

Significant HbA1c decrease every 3 months in goal attainers
0.21%
Significant reduction in diabetes distress and improvement in general dietary intake in goal attainers

Acceptability (IG)

High acceptability of TREAT-ON regardless of goal attainment

Original publication

Examining a Diabetes Self-Management Education and Support Telemedicine Model With High-Risk Patients in a Rural Community. J Diabetes Sci Technol. Published 20 June 2023. doi:10.1177/19322968231180884

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.